Ketamine and Psilocybin Update in Treatment-Resistant Depression
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of intimate partner violence.
The investigators observed a statistically significant relapse rate among those discontinuing medication for ADHD, which remained significant in subgroup analyses of both age groups.
Peer support is recognized by such bodies as the Substance Abuse and Mental Health Services Administration and the American Psychiatric Association as a valuable component of recovery-oriented services within systems of care.
Police killings of unarmed black Americans may have a negative impact on the mental health of this population.
Offenders with major psychopathic traits can be identified in all ethnic groups that have been studied, including European Americans, African Americans, and Latino Americans, but some of the evidence pointing to the validity of psychopathy is stronger in European Americans.
Mental health professionals regularly grapple with the best way to support clients navigating an onslaught of sexual violence in their daily lives.
Exploring the pathophysiology of lying and the patients who lie.
Deliberate practice, along with lessons from social psychology, can implement change in error disclosure.